Application of omics in Sjögren's syndrome
- PMID: 37878024
- DOI: 10.1007/s00011-023-01797-x
Application of omics in Sjögren's syndrome
Abstract
Objective: The pathogenesis, diagnosis, and treatment of Sjögren's syndrome (SS) face many challenges, and there is an urgent need to develop new technologies to improve our understanding of SS.
Methods: By searching the literature published domestically and internationally in the past 20 years, this artical reviewed the research of various omics techniques in SS.
Results: Omics technology provided valuable insights into the pathogenesis, early diagnosis, condition and efficacy evaluation of SS. It is helpful to reveal the pathogenesis of the disease and explore new treatment schemes, which will open a new era for the study of SS.
Conclusion: At present, omics research has made some gratifying achievements, but there are still many uncertainties. Therefore, in the future, we should improve research techniques, standardize the collection of samples, and adopt a combination of multi-omics techniques to jointly study the pathogenesis of SS and provide new schemes for its treatment.
Keywords: Genomics; Metabonomics; Microbiomics; Monocytomics; Proteomics; Transcriptomics.
© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Identification of drug targets for Sjögren's syndrome: multi-omics Mendelian randomization and colocalization analyses.Front Immunol. 2024 Jun 12;15:1419363. doi: 10.3389/fimmu.2024.1419363. eCollection 2024. Front Immunol. 2024. PMID: 38933282 Free PMC article.
-
Differential diagnosis of systemic lupus erythematosus and Sjögren's syndrome using machine learning and multi-omics data.Comput Biol Med. 2023 Jan;152:106373. doi: 10.1016/j.compbiomed.2022.106373. Epub 2022 Nov 28. Comput Biol Med. 2023. PMID: 36462367
-
Y RNA derived small RNAs in Sjögren's syndrome: Candidate biomarkers?Int J Rheum Dis. 2017 Nov;20(11):1763-1766. doi: 10.1111/1756-185X.13229. Epub 2017 Nov 19. Int J Rheum Dis. 2017. PMID: 29152879
-
The immune factors involved in the pathogenesis, diagnosis, and treatment of Sjogren's syndrome.Clin Dev Immunol. 2013;2013:160491. doi: 10.1155/2013/160491. Epub 2013 Jul 9. Clin Dev Immunol. 2013. PMID: 23935646 Free PMC article. Review.
-
Updates on Sjögren's syndrome: from proteomics to protein biomarkers.Expert Rev Proteomics. 2017 Jun;14(6):491-498. doi: 10.1080/14789450.2017.1333904. Epub 2017 May 26. Expert Rev Proteomics. 2017. PMID: 28532233 Review.
References
-
- Wen Z, Xioamei L, Dong X, Dongzhou L, Jian X, Futao Z, et al. Guidelines for diagnosis and treatment of primary Sjögren’s syndrome. Chin J Intern Med. 2020;59(4):269–76. https://doi.org/10.3760/cma.j.cn112138-20200113-00021 . (in Chinese). - DOI
-
- Segal BM, Nazmul-Hossain AN, Patel K, Hughes P, Moser KL, Rhodus NL. Genetics and genomics of Sjögren’s syndrome: research provides clues to pathogenesis and novel therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(6):673–80. https://doi.org/10.1016/j.tripleo.2011.01.040 . (Epub 2011 Apr 16. PMID: 21497524; PMCID: PMC3095716). - DOI - PubMed
-
- Jianguo W. Sjögren’s syndrome. J Clin Lab. 2022;40(02):138–40. https://doi.org/10.13602/j.cnki.jcls.2022.02.14 . (in Chinese). - DOI
-
- Dan M, Helin Y, Zewen W, Yazhen S, Liyun Z. Research progress of mesenchymal stem cells and their extracellular vesicles in the treatment of Sjögren’s syndrome. Chin J Rheumatol. 2020;24(09):634–7. https://doi.org/10.3760/cma.j.c141217-20190430-00153 . (in Chinese). - DOI
-
- Versura P, Giannaccare G, Vukatana G, Mulè R, Malavolta N, Campos EC. Predictive role of tear protein expression in the early diagnosis of Sjögren’s syndrome. Ann Clin Biochem. 2018;55(5):561–70. https://doi.org/10.1177/0004563217750679 . (Epub 2018 Jan 30. PMID: 29310465). - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous